Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Dolan

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Plos One|June 1, 2011
Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDSVincent C Marconi, Greg Grandits, Jason F Okulicz, et al.
Journal of Clinical Microbiology|May 8, 2003
Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapyRobert J O'Connell, Teresa M Merritt, Jennifer A Malia, et al.
AIDS Research and Therapy|January 20, 2011
Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohortAlan R Lifson, Elizabeth M Krantz, Lynn E Eberly, et al.
AIDS (London, England)|March 13, 2009
Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian childrenLudmila Shostakovich-Koretskaya, Gabriel Catano, Zoya A Chykarenko, et al.
Plos One|September 9, 2008
CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individualsHemant Kulkarni, Brian K Agan, Vincent C Marconi, et al.
The Journal of Infectious Diseases|October 27, 2009
Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history studyJason F Okulicz, Vincent C Marconi, Michael L Landrum, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2008
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progressionTrevor D Burt, Brian K Agan, Vincent C Marconi, et al.
Plos One|November 5, 2008
HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 allelesGabriel Catano, Hemant Kulkarni, Weijing He, et al.
AIDS (London, England)|July 19, 2006
Effectiveness of highly-active antiretroviral therapy by race/ethnicityMichael J Silverberg, Scott A Wegner, Mark J Milazzo, et al.
AIDS (London, England)|June 3, 2009
Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individualsMichael L Landrum, Katherine Huppler Hullsiek, Anuradha Ganesan, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Plos One|June 1, 2011
Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDSVincent C Marconi, Greg Grandits, Jason F Okulicz, et al.
Journal of Clinical Microbiology|May 8, 2003
Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapyRobert J O'Connell, Teresa M Merritt, Jennifer A Malia, et al.
AIDS Research and Therapy|January 20, 2011
Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohortAlan R Lifson, Elizabeth M Krantz, Lynn E Eberly, et al.
AIDS (London, England)|March 13, 2009
Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian childrenLudmila Shostakovich-Koretskaya, Gabriel Catano, Zoya A Chykarenko, et al.
Plos One|September 9, 2008
CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individualsHemant Kulkarni, Brian K Agan, Vincent C Marconi, et al.
The Journal of Infectious Diseases|October 27, 2009
Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history studyJason F Okulicz, Vincent C Marconi, Michael L Landrum, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2008
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progressionTrevor D Burt, Brian K Agan, Vincent C Marconi, et al.
Plos One|November 5, 2008
HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 allelesGabriel Catano, Hemant Kulkarni, Weijing He, et al.
AIDS (London, England)|July 19, 2006
Effectiveness of highly-active antiretroviral therapy by race/ethnicityMichael J Silverberg, Scott A Wegner, Mark J Milazzo, et al.
AIDS (London, England)|June 3, 2009
Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individualsMichael L Landrum, Katherine Huppler Hullsiek, Anuradha Ganesan, et al.
Pageof 4